Tianya Liu

Xi'an, 710004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Dual-targeted N-PMIplus@CA nanoplatform for concurrent MDM2 and β-catenin inhibition in p53 wild-type lung adenocarcinoma.

Dual-targeted N-PMIplus@CA nanoplatform for concurrent MDM2 and β-catenin inhibition in p53 wild-type lung adenocarcinoma.

Journal: Materials today. Bio

Published: June 07, 2025

Unlocking Wnt's weak spot: Glycosylated nanoalbumins to reignite immune responses in MSS-CRC.

Unlocking Wnt's weak spot: Glycosylated nanoalbumins to reignite immune responses in MSS-CRC.

Journal: Journal of pharmaceutical analysis

Published: March 22, 2025

Reactivating T cell immunity in Wnt-hyperactivated non-small cell lung cancer through a supramolecular droplet of carnosic acid and peptide.

Reactivating T cell immunity in Wnt-hyperactivated non-small cell lung cancer through a supramolecular droplet of carnosic acid and peptide.

Journal: Journal of pharmaceutical analysis

Published: December 16, 2024

Cracking melanoma's armor: Supramolecular dual-strike on XPO1 and β-catenin to overcome resistance.

Cracking melanoma's armor: Supramolecular dual-strike on XPO1 and β-catenin to overcome resistance.

Journal: Journal of advanced research

Published: November 06, 2024

Rebooting the Adaptive Immune Response in Immunotherapy-Resistant Lung Adenocarcinoma Using a Supramolecular Albumin.

Rebooting the Adaptive Immune Response in Immunotherapy-Resistant Lung Adenocarcinoma Using a Supramolecular Albumin.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: June 14, 2024

Small-molecule-induced liquid-liquid phase separation suppresses the carcinogenesis of β-catenin.

Small-molecule-induced liquid-liquid phase separation suppresses the carcinogenesis of β-catenin.

Journal: Nature communications

Published: April 22, 2024

An innovative gene expression modulating strategy by converting nucleic acids into HNC therapeutics using carrier-free nanoparticles.

An innovative gene expression modulating strategy by converting nucleic acids into HNC therapeutics using carrier-free nanoparticles.

Journal: Frontiers in immunology

Published: November 23, 2023

Modulating β-catenin/BCL9 interaction with cell-membrane-camouflaged carnosic acid to inhibit Wnt pathway and enhance tumor immune response.

Modulating β-catenin/BCL9 interaction with cell-membrane-camouflaged carnosic acid to inhibit Wnt pathway and enhance tumor immune response.

Journal: Frontiers in immunology

Published: August 08, 2023

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma.

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma.

Journal: Frontiers in immunology

Published: July 24, 2023

Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically.

Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically.

Journal: Journal of pharmaceutical analysis

Published: March 19, 2023

A Tumor-Targeting Metal-Organic Nanoparticle Constructed by Dynamic Combinatorial Chemistry toward Accurately Redressing Carcinogenic Wnt Cascade.

A Tumor-Targeting Metal-Organic Nanoparticle Constructed by Dynamic Combinatorial Chemistry toward Accurately Redressing Carcinogenic Wnt Cascade.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: August 12, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026